| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/14/2004 | EP1437363A1 Drug transporter and use thereof |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1436761A2 Nanomachine compositions and methods of use |
| 07/14/2004 | EP1436626A2 Method for selecting hla-dp4 ligands |
| 07/14/2004 | EP1436425A2 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436403A2 Use of the adenoviral e2 late promoter |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436396A2 A human g protein coupled receptor |
| 07/14/2004 | EP1436395A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436379A1 Dna fpr expression of alpha i-antitrypsin in methylotropic yeast |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436328A2 G-protein coupled receptor |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436326A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436325A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 07/14/2004 | EP1436324A1 Gene controlling life span of leaves in plants and method for controlling life span of plants using the gene |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436320A1 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 07/14/2004 | EP1436319A2 Repetitive motifs from salivary proline rich proteins, mucin and collagen |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436316A2 Subcellular targeting of therapeutic proteins |
| 07/14/2004 | EP1436315A2 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods |
| 07/14/2004 | EP1436233A2 Metal binding proteins and associated methods |
| 07/14/2004 | EP1436013A2 Method for inducing growth and enhancing survival of nervous tissue |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
| 07/14/2004 | EP1436001A1 Chicken anemia virus vaccine from cell line |
| 07/14/2004 | EP1435999A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 07/14/2004 | EP1435996A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 07/14/2004 | EP1435995A2 Composition and method for treating diabetes |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435986A2 Igf-binding protein-derived peptide or small molecule |
| 07/14/2004 | EP1435975A2 Methods of using 279, a human g protein-coupled receptor |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435914A1 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1435789A2 Hemocyanin nucleic acids and polypeptides and related vectors, fusion proteins, conjugates, cells and methods of use |
| 07/14/2004 | EP1435776A2 Anticancer vaccine and diganostic methods and reagents |
| 07/14/2004 | EP1435775A2 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes |
| 07/14/2004 | EP1372689B1 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
| 07/14/2004 | EP1342063A4 Assay for paralytic shellfish toxin |
| 07/14/2004 | EP1313440A4 Dental products comprising bone growth enhancing peptide |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP1194033A4 Transgenically produced antithrombin iii and mutants thereof |
| 07/14/2004 | EP1108009A4 Compositions and methods for producing high-level seed-specific gene expression in corn |
| 07/14/2004 | EP1049482A4 Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1513058A Secretory streptococcus pneumoniae proteins |
| 07/14/2004 | CN1513057A 宿主微生物 Host microorganisms |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511958A System of T cell surface antigen peptide screening human tissue compatibility antigen (HLA) and its application in producing MHC-antigen peptide polymer |
| 07/14/2004 | CN1511953A Construction of recombined human lymphotoxin alpha and producing process |
| 07/14/2004 | CN1511951A Method for reducing fruit size in plant |
| 07/14/2004 | CN1511849A Novel alpha interferon mutant and its preparing process |
| 07/14/2004 | CN1511848A Branched chain polyethylene glycol-integrated int3erferon composition and preparation |
| 07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
| 07/14/2004 | CN1511846A Ginkgo protein GAPIIa and its preparing method and use |
| 07/14/2004 | CN1511845A Candida albicans molecular companion gere and its use |
| 07/14/2004 | CN1511844A Pig pleuropneumonia actino bacillus gene engineering toxoid ApxI and dead bacterium mixed vaccine |
| 07/14/2004 | CN1511843A Novel cynthetic antibiotic peptide and its preparing method and use |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1157478C Improved barster gene |
| 07/14/2004 | CN1157411C Recombination method of substrate mediated membrane protein in lipid bilayer |
| 07/14/2004 | CN1157410C Human g-protein coupled receptor (HETGQ 23) |
| 07/14/2004 | CN1157409C Genetically engineered fish growth hormone and its use in aquatic product culture |
| 07/14/2004 | CN1157408C Agonist or antagonist of gluoprotein hormone activity existed in single-chain forms of glycoprotein hormone quartet |
| 07/14/2004 | CN1157407C Human interleukin-6 inhibitor |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/14/2004 | CN1157405C Preparation method of cholera toxin B sub unit |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762348 Genetic control of plant growth and development |
| 07/13/2004 | US6762347 NOR gene compositions and methods for use thereof |
| 07/13/2004 | US6762341 Treating asthma in animals; antiinflammatory/bronchodilator agents; drug screening |
| 07/13/2004 | US6762297 Comprise nucleotide sequences coding cyprinus growth hormone gene for generating transgenic fish with increased growth rates; animal husbandry |
| 07/13/2004 | US6762296 Antitumor protein and corresponding gene sequence isolated from matsutake mushrooms |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762294 Mutant gamma-aminobutyric acid (gabaa) subtype a receptor for monitoring human sensitivity to ethanol and benzodiazepine drugs such as diazepam; high throughput assays; alcoholism |
| 07/13/2004 | US6762291 Used to modify insects and worms, or cultured cells, resulting in p53 expression or mis-expression; modified organisms or cells are used in screening assays to identify potential pesticidal agents or therapeutics that interact with p53 |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762285 Bs2 resistance protein |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762281 Process for preparing peptide derivatized oligomeric compounds |
| 07/13/2004 | US6762280 High throughput assays for the proteotytic activities of clostridial neurotoxins |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762166 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |